NCT05142735View on ClinicalTrials.gov

Effects of NAC on Symptoms of CHR Patients

NARecruitingINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

January 13, 2023

Primary Completion Date

November 1, 2024

Study Completion Date

December 31, 2024

Conditions

Prodromal Schizophrenia

Interventions

DIETARY_SUPPLEMENT

N-Acetylcysteine

2000 mg (4 x 500-mg tablets) every morning

DIETARY_SUPPLEMENT

Placebo

4 placebo tablets every morning

Trial Locations (1)

M5T 1R8

RECRUITING

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors

lead

Centre for Addiction and Mental Health

OTHER